Insider Stock Trading History of Lamarche Jay R


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Lamarche Jay R since year 2005. The trader's CIK number is 1242998. At the time of this reporting, Lamarche Jay R is the Director of Ariad Pharmaceuticals Inc . (stock ticker symbol ARIA). See this page for all insider trading activities at Ariad Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Lamarche Jay R since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2012-10-01 ARIA Ariad Pharmaceuticals Inc Sale 10,000 24.99 249,930
2012-09-06 ARIA Ariad Pharmaceuticals Inc Option Ex 15,000 2.66 39,900
2012-08-15 ARIA Ariad Pharmaceuticals Inc Sale 20,000 20.00 400,040
2012-02-28 ARIA Ariad Pharmaceuticals Inc Option Ex 20,000 4.44 88,800
2012-01-27 ARIA Ariad Pharmaceuticals Inc Sale 26,900 15.06 404,979
2012-01-26 ARIA Ariad Pharmaceuticals Inc Sale 3,100 15.04 46,627
2011-05-09 ARIA Ariad Pharmaceuticals Inc Option Ex 25,000 5.65 141,250
2011-03-25 ARIA Ariad Pharmaceuticals Inc Sale 25,000 7.01 175,275
2011-02-02 ARIA Ariad Pharmaceuticals Inc Sale 25,000 6.48 161,925
2011-01-11 ARIA Ariad Pharmaceuticals Inc Sale 25,000 5.37 134,325
2010-12-20 ARIA Ariad Pharmaceuticals Inc Sale 25,000 5.00 125,125
2008-01-18 ARIA Ariad Pharmaceuticals Inc Option Ex 10,000 .00 0
2008-01-17 ARIA Ariad Pharmaceuticals Inc Option Ex 10,000 .00 0
2006-02-15 ARIA Ariad Pharmaceuticals Inc Option Ex 34,000 4.19 142,460
2006-02-14 ARIA Ariad Pharmaceuticals Inc Sale 25,300 6.54 165,462
2006-02-15 ARIA Ariad Pharmaceuticals Inc Sale 777 6.51 5,058

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lamarche Jay R (Director of Ariad Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.